Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM—a prospective, randomized, single-centre, open-label study

Autor:	Niklas Broman, Thijs Feuth, Tytti Vuorinen, Mika Valtonen, Ulla Hohenthal, Eliisa Löyttyniemi, Tiina Hirvioja, Päivi Jalava-Karvinen, Harri Marttila, Marika Nordberg, Jarmo Oksi
Rok vydání:	2022
Předmět:	Microbiology (medical) Infectious Diseases General Medicine
Zdroj:	Clinical Microbiology and Infection. 28:844-851
ISSN:	1198-743X
DOI:	10.1016/j.cmi.2022.02.027
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::6bdab191f3596491400b62b7217b7453 https://doi.org/10.1016/j.cmi.2022.02.027 Zobrazit plný text záznamu